The fraction of the primary circulating estrogen, estradiol (E2), that is unbound to plasma proteins, specifically Sex Hormone-Binding Globulin (SHBG) and albumin. This unbound portion is the biologically active component capable of diffusing into target cells to interact with estrogen receptors and initiate cellular signaling. Clinically, measuring this fraction provides a more accurate assessment of estrogenic activity than total estradiol.
Origin
This is a core concept in clinical endocrinology, derived from the ‘Free Hormone Hypothesis,’ which posits that only the unbound hormone is available for biological action. ‘Estradiol’ is from the Greek oistros (mad desire) and ‘free’ denotes its non-complexed state in the circulation. Its measurement is vital for diagnosing estrogen deficiency or excess states.
Mechanism
Estradiol is largely transported in the blood bound to SHBG and albumin; only the small free fraction is bioavailable. Because SHBG binding affinity is high, changes in SHBG concentration—due to liver function, thyroid status, or genetic factors—significantly impact the free estradiol level. The free molecule enters the cell, binds to the estrogen receptor, and the complex then regulates gene transcription to mediate estrogen’s diverse physiological effects.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.